申请人:Zhang Penglie
公开号:US20070066583A1
公开(公告)日:2007-03-22
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
提供了一些化合物,它们作为CCR1受体的有效拮抗剂,并具有体内抗炎活性。这些化合物通常是单环和双环化合物,并可用于制药组合物、治疗CCR1介导疾病的方法,以及作为竞争性CCR1拮抗剂鉴定的控制。